Imaging platform

Circle Oncodesign Services

Using imaging technologies in Drug Development


Pharmaco-imaging is the key to understanding the action of a new drug on the diseases studied. Thanks to Oncodesign Services advanced technologies such as MRI, SPECT/CT, PET/MR, CT, or Optical Imaging, you can explore the body on a micro and macroscopic scale and obtain valuable translational data.

Key benefits of imaging tools in Drug Development

Constantly evolving, preclinical imaging is transforming medicine and Drug Discovery. As a specialized CRO, we are convinced of the contribution of imaging to your preclinical programs:

  • Non-invasive and serial tumor monitoring
  • Decrease the number of animals used
  • Characterization of drug mechanism of action
  • Early and predictive evaluation of drug potency

This helps accelerate the drug discovery process, , and optimize treatment protocols more quickly.


Example of modalities in imaging platform

  • Magnetic Resonance Imaging (MRI)
  • Nuclear imaging (PET/CT, SPECT/CT, PET/MR)
  • Optical imaging (Bioluminescence, Fluorescence)
  • Ultrasound


Oncodesign Services imaging platform to support your drug development

Oncodesign Services provides imaging services throughout the drug development process for:


Preclinical Imaging Services | Multimodal technologies to understand the pharmacology

Oncodesign Services’ in vivo multi-modal imaging platform can be used for biodistribution studies, tumor tracking and to detect biomarkers of activity.


Get in touch

DRIVE-MRT: a premium “nuclear medicine” solution in Oncology​

DRIVE-MRT is part of our continuous improvement in the integrated drug discovery support. Oncodesign Services and its strategic partners CovalabCheMatech, and ABX-CRO are applying their expertise in the rationalization, design, and optimization of targeted radiopharmaceutical agents.

More information